Back to BlackBarn Capital Partners LP
Q2 2026 13F filing
Updated 27 days ago24 disclosed positions worth $1.2B
Portfolio value
$1.2B
Total holdings
24
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-08-14
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SPY SPDR S&P 500 ETF TR | $597.4M | 800.0K | 50.40% | — |
| 2 | R ROIV ROIVANT SCIENCES LTD | $70.8M | 2.00M | 5.97% | — |
| 3 | O OSCR OSCAR HEALTH INC | $49.9M | 1.75M | 4.21% | — |
| 4 | U UNH UNITEDHEALTH GROUP INC | $41.6M | 100.0K | 3.51% | — |
| 5 | P PRVA PRIVIA HEALTH GROUP INC | $40.8M | 1.58M | 3.44% | — |
| 6 | R RSMDF RESMED INC | $39M | 200.0K | 3.29% | — |
| 7 | D DHCNL DIVERSIFIED HEALTHCARE TR | $37.9M | 4.08M | 3.20% | — |
| 8 | V VG VENTURE GLOBAL INC | $33.4M | 3.00M | 2.82% | — |
| 9 | N NEE-PS NEXTERA ENERGY INC | $29.4M | 335.0K | 2.48% | — |
| 10 | N NIQ NIQ GLOBAL INTELLIGENCE PLC | $27.2M | 2.90M | 2.29% | — |
| 11 | U UNH UNITEDHEALTH GROUP INC | $27M | 65.0K | 2.28% | — |
| 12 | N NXPI NXP SEMICONDUCTORS N V | $25.3M | 90.0K | 2.13% | — |
| 13 | V VIK VIKING THERAPEUTICS INC | $23.4M | 600.0K | 1.97% | — |
| 14 | M MH MCGRAW HILL INC | $23.2M | 2.45M | 1.96% | — |
| 15 | A AMRX AMNEAL PHARMACEUTICALS INC | $22.5M | 1.30M | 1.90% | — |
| 16 | V VG VENTURE GLOBAL INC | $19.5M | 1.75M | 1.64% | — |
| 17 | ? N/A AZUL S A | $15.1M | 1.68M | 1.28% | — |
| 18 | O OXY-WT OCCIDENTAL PETE CORP | $12.1M | 250.0K | 1.02% | — |
| 19 | W WRBY WARBY PARKER INC | $12.1M | 400.0K | 1.02% | — |
| 20 | A ABUS ARBUTUS BIOPHARMA CORP | $12M | 2.50M | 1.01% | — |
| 21 | V VIK VIKING THERAPEUTICS INC | $9.8M | 250.0K | 0.82% | — |
| 22 | C CRC CALIFORNIA RES CORP | $9.3M | 175.0K | 0.78% | — |
| 23 | C CCOI COGENT COMMUNICATIONS HLDGS | $3.5M | 250.0K | 0.29% | — |
| 24 | S SEATW VIVID SEATS INC | $3.3M | 500.0K | 0.28% | — |